Literature DB >> 3021862

Epidermis and lymphocyte interactions during a tuberculin skin reaction. II. Epidermis contains specific lymphocyte chemotactic factors.

T Ternowitz, K Thestrup-Pedersen.   

Abstract

Lymphocyte chemotaxis was studied in a blind-well chamber assay by measuring the passage of 51Cr-labeled cells through a polycarbonate filter with a pore size of 5 micron. Monocyte-depleted lymphocytes were divided into T cells (E receptor-positive lymphocytes) and non-T cells. T lymphocytes showed pronounced migration after exposure to leukotriene B4 (LTB4) and casein, and weak migration after exposure to N-formyl-methionyl-leucyl-phenylalanine (FMLP). Non-T cells showed strong migration after exposure to FMLP, but weak migration after exposure to casein and LTB4. Supernatants of homogenized suction blisters from normal skin did not induce active migration. However, if the epidermis came from an area overlying a positive tuberculin skin reaction, there was a significant migration mostly of T, but also of non-T cells. Supernatants from phytohemagglutinin (PHA)-stimulated lymphocyte cultures also contained lymphocyte chemotactic factor(s), which, however, had an effect only on T lymphocytes. Purified protein derivative of tuberculin (PPD)-stimulated lymphocytes did not produce chemoattractants either for T or for non-T cells. These studies show that lymphocytes can show active, directed migration following exposure to well-known chemotaxins for granulocytes and monocytes although their migrational capability differs for different subpopulations. Epidermis overlying a cell-mediated immune reaction (tuberculin) contains epidermal lymphocyte chemotactic factor(s). This factor(s) may be of importance for the type of cell infiltrate occurring in certain dermatologic disorders.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021862     DOI: 10.1111/1523-1747.ep12455858

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Lymphocyte subsets and their proliferation in a model for a delayed-type hypersensitivity reaction in the skin.

Authors:  F J Fritz; R Pabst; R M Binns
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

2.  Marked synergism between tumor necrosis factor-alpha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors.

Authors:  J N Barker; V Sarma; R S Mitra; V M Dixit; B J Nickoloff
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  Epidermal lymphocyte chemotactic factor specifically attracts OKT4-positive lymphocytes.

Authors:  C Zachariae; T Ternowitz; C G Larsen; V Nielsen; K Thestrup-Pedersen
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

4.  Epidermis and lymphocyte interactions during a tuberculin skin reaction. I. Increased ETAF/IL-1 like activity, expression of tissue antigens and mixed skin lymphocyte reactivity.

Authors:  C G Larsen; T Ternowitz; F G Larsen; K Thestrup-Pedersen
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

5.  Adhesion of T and B lymphocytes to fibroblasts in tissue culture.

Authors:  D Abraham; H Muir; I Olsen
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

6.  Human T lymphocytes and T-cell lines as target cells for lymphocyte chemotaxis.

Authors:  C O Zachariae; K Kaltoft; K Thestrup-Pedersen
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

7.  Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid.

Authors:  K B Bacon; R D Camp; F M Cunningham; P M Woollard
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

8.  Phenotypic determination of T-lymphocytes responding to chemotactic stimulation from fMLP, IL-8, human IL-10, and epidermal lymphocyte chemotactic factor.

Authors:  C O Zachariae; T Jinquan; V Nielsen; K Kaltoft; K Thestrup-Pedersen
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.